News
-
-
-
-
PRESS RELEASE
Edisun Power shows solid results and announces new CEO for strategic focus on « Renewables to AI »
Edisun Power reports solid results with increased sales and EBITDA margin. José María Llopis appointed new CEO for strategic focus on 'Renewables to AI'. Proposed dividend waiver for 2024 due to major investments -
-
PRESS RELEASE
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for COPD patients based on pivotal phase 3 results in adults with elevated eosinophils, marking a new treatment approach for COPD -
-
-
-
PRESS RELEASE
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more
